Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For the study group and first comparison group:
- People who are 18 years of age or older
- People who have been diagnosed with any stage of DCIS (a very early form of breast cancer) or primary breast cancer, including all types
- People who are planning to have surgery that involves complete or near-complete breast removal, with or without insertion of an implant or tissue expander
- People who are able and willing to provide written consent to participate
For the second and third comparison groups:
- People who are 18 years of age or older
- People who are planning to have surgery that involves an implant or tissue expander, with or without breast removal
- People who are able and willing to provide written consent to participate
Who may not be able to join:
- People under 18 years of age
- People who are male
- Breast cancer patients whose planned surgery is breast-conserving (meaning only part of the breast is removed)
- People whose breast cancer has come back after previous treatment
- People who have had previous breast surgery of any kind
- People whose only diagnosis is LCIS (a specific condition found in breast cells, without a breast cancer diagnosis) (confirm with trial site)
- People who are pregnant at the time of diagnosis
- People who have a known condition that weakens the immune system
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Thorsten Kühn, Prof., Eubreast Network, Baumreute 37 D-73730 Esslingen, Germany
Phone: +49 (0)821 400 165809
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identification of a patient population at increased risk for developing seroma.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.